VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $7,407,000 | -20.3% | 41,526 | -0.7% | 0.02% | -10.5% |
| Q2 2015 | $9,292,000 | -43.9% | 41,826 | -49.9% | 0.02% | -42.4% |
| Q1 2015 | $16,575,000 | +34.7% | 83,452 | -2.9% | 0.03% | +32.0% |
| Q4 2014 | $12,304,000 | -38.8% | 85,977 | -43.9% | 0.02% | -41.9% |
| Q3 2014 | $20,107,000 | +41.2% | 153,255 | +35.7% | 0.04% | +38.7% |
| Q2 2014 | $14,245,000 | +2976.7% | 112,943 | +2765.1% | 0.03% | +3000.0% |
| Q4 2013 | $463,000 | +12.7% | 3,942 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $411,000 | -92.6% | 3,942 | -93.9% | 0.00% | -93.8% |
| Q2 2013 | $5,518,000 | – | 64,099 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |